Your browser doesn't support javascript.
loading
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Christy L. Lavine; Shaun Rawson; Haisun Zhu; Krishna Anand; Pei Tong; Avneesh Gautam; Shen Lu; Sarah Sterling; Richard M Walsh Jr.; Jianming Lu; Wei Yang; Michael S Seaman.
Afiliação
  • Christy L. Lavine; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center
  • Shaun Rawson; SBGrid Consortium, Harvard Medical School
  • Haisun Zhu; Institute for Protein Innovation, Harvard Institutes of Medicine
  • Krishna Anand; Institute for Protein Innovation, Harvard Institutes of Medicine
  • Pei Tong; Harvard Medical School
  • Avneesh Gautam; Harvard Medical School
  • Shen Lu; Codex BioSolutions, Inc
  • Sarah Sterling; The Harvard Cryo-EM Center for Structural Biology/Harvard Medical School
  • Richard M Walsh Jr.; The Harvard Cryo-EM Center for Structural Biology/Harvard Medical School
  • Jianming Lu; Codex BioSolutions, Inc.
  • Wei Yang; Institute for Protein Innovation, Harvard Institutes of Medicine
  • Michael S Seaman; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center
Preprint em Inglês | bioRxiv | ID: ppbiorxiv-439709
ABSTRACT
Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains that continue to fuel the COVID-19 pandemic despite intensive vaccination efforts throughout the world. We report here cryo-EM structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Mutations in the B.1.1.7 protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-converting enzyme 2 (ACE2). The enhanced receptor engagement can account for the increased transmissibility and risk of mortality as the variant may begin to infect efficiently infect additional cell types expressing low levels of ACE2. The B.1.351 variant has evolved to reshape antigenic surfaces of the major neutralizing sites on the S protein, rendering complete resistance to some potent neutralizing antibodies. These findings provide structural details on how the wide spread of SARS-CoV-2 enables rapid evolution to enhance viral fitness and immune evasion. They may guide intervention strategies to control the pandemic.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
...